# FDA Inspection 1166414 - The Blood Center - March 09, 2022

Source: https://www.keypedia.com/records/fda_inspections/the-blood-center/33f7dbc6-bad2-4e38-a608-865986a2fee8
Source feed: FDA_Inspections

> FDA Inspection 1166414 for The Blood Center on March 09, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166414
- Company Name: The Blood Center
- Inspection Date: 2022-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1063944 - 2018-07-25](https://www.keypedia.com/records/fda_inspections/the-blood-center/7177dd81-d705-4ff5-aea2-ccbd27ff246f)
- [FDA Inspection 982410 - 2016-06-14](https://www.keypedia.com/records/fda_inspections/the-blood-center/97b3930a-5be3-4556-b63b-87f025af4fd1)
- [FDA Inspection 872717 - 2014-04-01](https://www.keypedia.com/records/fda_inspections/the-blood-center/f23c3b6d-a1e1-40c9-9bb6-1935eaea8db4)
- [FDA Inspection 806794 - 2012-10-17](https://www.keypedia.com/records/fda_inspections/the-blood-center/e56a4d7a-547f-47b8-9aa9-9495aecf076d)
- [FDA Inspection 708509 - 2011-01-26](https://www.keypedia.com/records/fda_inspections/the-blood-center/17a4c111-6c5c-4c0f-9eb9-9c2674117418)

Company: https://www.keypedia.com/companies/the-blood-center/19e79376-3ce4-4b69-9380-ace2ae41efcc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d